Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.438.0324.0616.719.66

What is the latest EV/Core EBITDA ratio of TTK HEALTHCARE ?

The latest EV/Core EBITDA ratio of TTK HEALTHCARE is 13.43 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.43
Mar20238.03
Mar202224.06
Mar202116.71
Mar20209.66

How is EV/Core EBITDA of TTK HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2024 13.43
67.25
Mar2023 8.03
-66.63
Mar2022 24.06
43.99
Mar2021 16.71
72.98
Mar2020 9.66 -

Other Financial Ratios of TTK HEALTHCARE


Compare EV/Core EBITDA ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,678.0 Cr -0.5% -8% -18.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,617.0 Cr -2.1% -9% 9.1% Stock Analytics
DIVIS LABORATORIES ₹158,655.0 Cr 2.4% 2.2% 59.7% Stock Analytics
CIPLA ₹119,511.0 Cr 1.4% 2% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,734.0 Cr -0.9% -2.8% 16.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,705.1 Cr -2.1% -9.2% -8.7% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-0.5%

-8%

-18.9%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses